N4 Pharma Plc (LON:N4P – Get Free Report)’s share price dropped 2.2% during trading on Tuesday . The stock traded as low as GBX 0.41 ($0.01) and last traded at GBX 0.44 ($0.01). Approximately 106,689 shares were traded during trading, a decline of 89% from the average daily volume of 1,011,828 shares. The stock had previously closed at GBX 0.45 ($0.01).
N4 Pharma Price Performance
The business has a 50 day simple moving average of GBX 0.58 and a two-hundred day simple moving average of GBX 0.73. The firm has a market capitalization of £1.18 million, a P/E ratio of -44.00 and a beta of -0.07. The company has a debt-to-equity ratio of 1.62, a quick ratio of 7.28 and a current ratio of 14.86.
N4 Pharma Company Profile
N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
Read More
- Five stocks we like better than N4 Pharma
- The How And Why of Investing in Oil Stocks
- Tech Leader’s Stock Split: Is It the Right Time to Buy?
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Could the Economy be Bottoming? Major Bank’s Earnings Say Yes
- Investing in the High PE Growth Stocks
- Seize This Prime Stock Opportunity on Amazon Prime Days
Receive News & Ratings for N4 Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for N4 Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
